新的临床PET标记剂正在为黑色素瘤提供管道
Nora Jaber1, Hanna Saadani2,3, Winnie Schats4
1Department of Nuclear Medicine, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Current oncology reports
|March 12, 2025
概括
新的正电子发射断层扫描 (PET) 标记器正在出现用于黑色素瘤的检测和监测. 虽然[18F]FDG PET/CT是标准的,但针对黑色素,FAP和免疫细胞的新标记物显示出提高准确性的承诺.
科学领域:
- 在瘤学瘤学.
- 核医学就是核医学.
- 放射化学 放射化学是指辐射化学.
背景情况:
- FDG PET/CT是治疗黑色素瘤的一个有价值的工具,但缺乏特异性.
- 对黑色素瘤更精确的PET成像剂有显著的临床需求.
研究的目的:
- 审查正在开发的黑色素瘤新型临床正子发射断层扫描 (PET) 标记剂.
- 为了将这些新标记物与当前标准进行比较,FDG PET/CT,如果可能的话.
主要方法:
- 对正在进行的关于PET标记物对黑色素瘤的临床研究的文献综述.
- 标记剂分为四大组:黑素向,FAP抑制剂,PD-1/PD-L1抑制剂和CD8+ T细胞标记剂.
主要成果:
- 色素向标记物和FAP抑制剂显示出黑色素瘤诊断和转移检测的潜力.
- 在评估和预测治疗反应方面,PD-1/PD-L1和CD8+T细胞标记物显示出有前途.
- 目前的研究表明有希望的结果,但需要更大的患者队列.
结论:
- 新兴的PET追踪剂比黑色素瘤的FDG提供了更好的特异性和功能.
- 黑色素,FAP,PD-1/PD-L1和CD8+T细胞的痕迹体代表了黑色素瘤PET成像进步的关键领域.
- 在更大的患者群体中进行进一步的临床验证对于确定这些新型标记物的有用性至关重要.
相关概念视频
Positron Emission Tomography
4.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
65
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
65

![Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F55537.jpg&w=3840&q=50)
